Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 3 (2006), Issue 6 (June)

1. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.
   Int J Radiat Oncol Biol Phys, 65(3): 809-16. [Abstract] [Full-text]
2. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers.
   Int J Radiat Oncol Biol Phys, 65(3): 788-99. [Abstract] [Full-text]
3. Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10 Gy).
   Int J Radiat Oncol Biol Phys, 65(3): 800-8. [Abstract] [Full-text]
4. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
   J Neurol Sci, 246(1): 85-94. [Abstract] [Full-text]
5. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
   JAMA, 295(21): 2483-91. [Abstract] [Full-text]
6. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
   J Clin Endocrinol Metab, 91(6): 2257-63. [Abstract] [Full-text]
7. Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas.
   J Clin Endocrinol Metab, 91(6): 2225-31. [Abstract] [Full-text]
8. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.
   J Clin Endocrinol Metab, 91(6): 2112-8. [Abstract] [Full-text]
9. The role of endogenous growth hormone-releasing hormone in acromegaly.
   J Clin Endocrinol Metab, 91(6): 2185-90. [Abstract] [Full-text]
10. Cerebral metastases pathology after radiosurgery: a multicenter study.
    Cancer, 106(12): 2672-81. [Abstract] [Full-text]
11. Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989.
    Int J Cancer, 119(5): 1136-44. [Abstract] [Full-text]
12. CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis.
    Pediatr Blood Cancer, 47(2): 169-73. [Abstract] [Full-text]
13. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Pediatr Blood Cancer, 47(2): 174-82. [Abstract] [Full-text]
14. Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.
    Arch Ophthalmol, 124(6): 885-6. [Abstract] [Full-text]
15. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
    Neurology, 66(11): 1661-7. [Abstract] [Full-text]
16. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
    Biopolymers, 82(4): 301-5. [Abstract] [Full-text]
17. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
    J Clin Oncol, 24(18): 2715-22. [Abstract] [Full-text]
18. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
    J Clin Oncol, 24(18): 2707-14. [Abstract] [Full-text]
19. Papillary glioneuronal tumor: a case report and review of the literature.
    Hum Pathol, 37(7): 914-8. [Abstract] [Full-text]
20. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
    Hum Pathol, 37(7): 854-60. [Abstract] [Full-text]
21. Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review.
    Hum Pathol, 37(7): 845-53. [Abstract] [Full-text]
22. Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation.
    Am J Phys Med Rehabil, 85(7): 568-73. [Abstract] [Full-text]
23. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.
    J Neurosci, 26(25): 6781-90. [Abstract] [Full-text]
24. Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
    Int J Radiat Oncol Biol Phys, 65(4): 1192-9. [Abstract] [Full-text]
25. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.
    Neurology, 66(12): 1899-906. [Abstract] [Full-text]
26. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
    Brain, 129: 1884-91. [Abstract] [Full-text]
27. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    J Clin Oncol, 24(19): 3142-9. [Abstract] [Full-text]

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.